Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
Introduction: Adoptive cell therapy using tumor-infiltrating lymphocytes (TILs) has proved to be an effective treatment for metastatic melanoma, even in patients failing anti-PD-1 blockade. Nevertheless, progression is observed in a substantial subgroup of patients following an initial objective res...
Saved in:
| Main Authors: | Rikke Andersen, Troels Holz Borch, Eva Ellebaek, Inge Marie Svane, Helle Westergren Hendel, Kasper Madsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/2/e010575.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
by: Marco Donia, et al.
Published: (2020-10-01) -
Biomarkers for response to TIL therapy: a comprehensive review
by: Marco Donia, et al.
Published: (2024-03-01) -
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma
by: T.J. Monberg, et al.
Published: (2024-12-01) -
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma
by: Morten Nielsen, et al.
Published: (2024-12-01) -
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
by: Mélanie Saint-Jean, et al.
Published: (2018-01-01)